Skip to main content

Advertisement

Log in

Tracer imaging in lung cancer

  • Letters to the Editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Abdel-Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nucl Med 1994; 21:57–81.

    Google Scholar 

  2. Leitha T, Walter R, Schlick W, Dudczak R. 99mTc-Anti-CEA radioimmunoscintigraphy of lung adenocarcinoma. Chest 1991;99:14–19.

    Google Scholar 

  3. Leitha T, Baur M, Steger G, Dudczak R. Anti-CEA immunoscintigraphy in the postoperative care of tumor patients. Differentiated use of several monoclonal antibody preparations. Wien Min Wochenschr 1990; 17:503–509.

    Google Scholar 

  4. Leitha T, Meghdadi S, Studnicka M, Wolzt M, Marosi C, Angelberger P, Neumann M, Schlick W, Metter K, Dudczak R. The role of 1231-Tyr-3-octreotide scintigraphy in the staging of small cell lung cancer. J Nucl Med 1993; 34:1397–1402.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leitha, T., Staudenherz, A. & Kletter, K. Tracer imaging in lung cancer. Eur J Nucl Med 21, 369–370 (1994). https://doi.org/10.1007/BF00176581

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00176581

Keywords

Navigation